Cargando…
Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer
Identification of molecular subtypes that reflect different prognoses and treatment responses, especially immune checkpoint inhibitors (ICIs) in esophageal squamous cell carcinoma (ESCC), is essential for treatment decisions. We performed targeted sequencing in 201 patients with ESCC to discover gen...
Autores principales: | Mai, Zihang, Yuan, Jianye, Yang, Hong, Fang, Shuogui, Xie, Xiuying, Wang, Xinye, Xie, Jiaxin, Wen, Jing, Fu, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462502/ https://www.ncbi.nlm.nih.gov/pubmed/35993362 http://dx.doi.org/10.1172/jci.insight.155218 |
Ejemplares similares
-
Integration of Tumor Heterogeneity for Recurrence Prediction in Patients with Esophageal Squamous Cell Cancer
por: Mai, Zihang, et al.
Publicado: (2021) -
Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node‐positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
por: Fang, Shuogui, et al.
Publicado: (2022) -
Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma
por: Wen, Jing, et al.
Publicado: (2022) -
Hippo inactivation feeds tumor-initiating cells
por: Duss, Stephan, et al.
Publicado: (2012) -
KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma
por: Sun, Xiaozheng, et al.
Publicado: (2020)